Head and neck cancer in geriatric patients: Analysis of the pattern of care given at a tertiary cancer care center

• Published in: Indian journal of cancer 2015-07, Vol.52 (3), p.387
• Main Authors: Thiagarajan, S, Babu, Tps, Chakraborthy, S, Patil, V, Bhattacharjee, A, Balasubramanian, S
• Format: Article
• Language: English
• Subjects: Care and treatment; Diagnosis; Elderly patients; Head and neck cancer; Health aspects; Management; Medical care; Risk factors
• ISSN: 0019-509X; 1998-4774
• DOI: 10.4103/0019-509X.176734

Background And Aim: The percentage of elderly people with head and neck cancers (HNC) is on the rise. This makes HNC in this group of patients an important issue for healthcare providers. The present study was planned to analyze the patterns of care given to the geriatric patients and to identify the factors influencing the decision making process. Materials And Methods: Data of all the elderly patients (>65 years) registered in the year 2012, with histologically proven HNC (all sites, stages, histopathological types, except lymphoma, sarcoma and cervical metastasis of unknown origin) receiving treatment (definitive/palliative) were collected. Results: A total of 270 patients were included in this study. The median age was 72 years (range: 65-101), with predominant male population (70%, n = 190). Oral cavity squamous cell carcinoma (SCC) was the most common cancer (57%, n = 154). Eastern Co-Operative Oncology Group performance status (PS) of 0-2 was seen in 91% of the patients. Co-morbidities were present in 139 (51.5%) patients. 50% (n = 134) of the patients received palliative intent treatment, 45% (n = 123) definitive treatment, whereas in 5% (n = 13) the intent was not mentioned. Age, a clinical stage and PS significantly influenced the decision making on the intent of treatment. 208 (77%) patients completed their treatment irrespective of the intent. Age was the only factor influencing treatment completion irrespective of the intent. Conclusion: Geriatric HNC patients frequently present with advanced disease, having multiple co-morbidities. Hence, a multidisciplinary team management of these patients is essential, also taking into account of the social and financial support available to these patients.